4 | SEC Filings Hub

Filing metadata

Accession number: 0001628280-21-001279
Form type: Form 4
Filer: Aurinia Pharmaceuticals Inc.
CIK: CIK 1600620
Filed: Feb 02, 2021
Reporting period: Jan 29, 2021
Description: Insider transaction

Documents

0001628280-21-001279-index.htm

Complete submission

0001628280-21-001279.txt

directory listing

Filed by

Aurinia Pharmaceuticals Inc.